Founded in 1991 by his current CEO (Benoît Deschamps) and his spouse (Colette Delvigne), the company showed an early interest in Good Distribution Practice.
A soon as 1994, Medilog edited for the Belgian market the first quality manual aimed for the Belgian wholesaler-distributors grouped within the ANGR (Association Nationale des Grossistes Répartiteurs).
In 2002, MEDILOG has started, in full agreement with FAMHP (federal agency for medicine and health products) to exercise the function of “Responsible Person” (according to the 2.2 GDP principles) for several “ WDA” ( Wholesale Distributor Autorisation) authorisation holders in Belgium.
MEDILOG has also become “local contact point for pharmaceutical and materiovigilance” for many AMM holders or Belgian or European medical devices distributors.
In 2017, the world leader in pharmaceutical distribution has asked MEDILOG to be their responsible person for their freshly acquired compagnies in Belgium and to harmonize their quality manuals.
Since then, Medilog has split in two distinct entities where Medilog Consulting Sprl focussed on activities linked to distribution of drugs, medical devices and nutritional supplements.
To lead their missions Medilog Consulting can count on an experienced multilingual team.
To date, our team is made up of :
Hubert DESCHAMPS
our specialist DCIM
(Data Collection & Integrity Manager)
Robert CORMAN
our specialist in
MARKETING
Marc DESCHAMPS
our specialist in
STRATÉGIE
Benoît DESCHAMPS
Colette DELVIGNE
Hélène DESCHAMPS
Samuel VAN BAEL
our PHARMACISTS, formed to GDP and GPP (Good Pharmacy Practice)
REFERENCES
MEDILOG Consulting currently works for around twenty companies active in the field of pharmaceutical distribution.
These firms cover the following range of activities: storage (including radionuclides), distribution, non-GMP packaging, export, transit, transport (ambient at -24 ° C), promotion and pharmacy.
These customers are either large international groups, their Belgian subcontractors, or smaller companies who do not wish to incur the costs of an internal "GDP" service.